Prof. Dr. Rolf Berger is a Professor of Pediatrics at the Faculty of Medical Sciences, University of Groningen , specializing in Pediatric and Congenital Cardiology . His research focuses on pulmonary hypertension , congenital heart disease , and cardiovascular outcomes in pediatric populations. He is affiliated with the Vascular Medicine (VASC) and Cardiovascular Centre (CVC) at UMCG. ORCID: 0000-0002-4385-5784 Contact: r.m.f.berger@umcg.nl | +31 50 361 4159 Research Interests Pediatric Pulmonary Hypertension Congenital Heart Disease Vascular Compliance and Remodeling Cardiovascular Imaging (MRI, Accelerometry) Machine Learning in Cardiovascular Diagnostics Scientific Contributions include 294+ publications and organizing the European Conference on Neonatal and Paediatric Pulmonary Vascular Disease (6th edition in 2024). Notable work involves physical activity monitoring in children, hemodynamic prediction models , and Fontan circulation outcomes. Supervised PhD student M.J. Mebius and contributed to datasets on angiogenic proteins and oxygen saturation in infants.
Weihua Zhou is a Tenured Associate Professor at Michigan Technological University in the College of Computing, with affiliations in Applied Computing, Biomedical Engineering, Computer Science, Electrical and Computer Engineering, and Mathematical Sciences. He holds a PhD from Southern Illinois University Carbondale, an MS and B.Eng. from Wuhan University, and completed postdoctoral research at Emory University. Academic Positions : Tenured Associate Professor (2025–present), Tenure-Track Assistant Professor (2019–2025) at Michigan Tech; Nina Bell Suggs Endowed Professorship (2015–2019) at the University of Southern Mississippi. Research Interests : Focuses on medical imaging and health informatics , particularly machine learning applications in cardiovascular diagnosis , osteoporosis risk stratification , and senile dementia early detection . Additional work includes radiomics for COVID-19 severity assessment , federated learning in medical segmentation , and deep learning for proximal femur strength prediction . Scientific Awards : USM Nina Bell Suggs Endowed Professorship, USM College of Arts and Sciences Scholarly Research Award, American Heart Association Research Leaders Academy (2017, 2018), USM Butch Oustalet Distinguished Professorship Research Award. Lab & Tools : Leads the Medical Imaging & Informatics Lab (MIILab-MTU) and contributes to the NSF/MRI GPU Cluster. Open-sourced tools include KD4COVID19 for radiomics analysis and ECGTools for ECG classification.
Brett Meyers is an Assistant Research Professor at Purdue University's College of Engineering, specializing in biomedical engineering and cardiovascular fluid dynamics. His research focuses on advancing echocardiographic techniques, computational fluid dynamics (CFD), and medical imaging technologies to assess cardiac function in patients with congenital heart defects, sepsis, and other cardiovascular conditions. Key contributions include developing the Doppler Velocity Reconstruction (DoVeR) method and enhancing fetal/neonatal echocardiography for early diagnosis. Education details are not explicitly stated in the provided text. His work spans pediatric cardiology, adult heart failure, and biomaterials, with a strong emphasis on translational research. Meyers has pioneered methods to quantify intracardiac flow patterns using 4D flow MRI and ultrasound-based techniques like EchoPIV (Echocardiographic Particle Image Velocimetry). Research interests include hemodynamic biomarker development for sepsis prognostication, single ventricle heart biomechanics, and fluid mechanics in biological systems (e.g., snake tongue flicking). He has authored over 50 peer-reviewed articles since 2013, with recent work focusing on AI-driven analysis of echocardiograms and novel drug delivery systems using synchrotron imaging. While no specific awards are listed, his innovative methodologies have been applied in clinical settings, such as assessing exercise capacity in repaired Tetralogy of Fallot patients and refining therapeutic regimens for thrombotic disorders. Meyers collaborates with multidisciplinary teams in Purdue's biomedical engineering and mechanical engineering departments, contributing to both academic and industrial partnerships.
Laura Almasy serves as Professor of Genetics in the Department of Genetics at the University of Pennsylvania, with affiliations in the Genomics and Computational Biology Graduate Group. Her work bridges statistical genetics, neuroimaging, and complex trait analysis across psychiatric and cardiovascular domains. Her academic foundation includes a B.A. in Biology and Psychology from Swarthmore College (1990), followed by an M.Phil. (1992) and Ph.D. (1996) in Genetics from Yale University. Postdoctoral training was completed at the Southwest Foundation for Biomedical Research (1996-1998). Research centers on genetic architecture of complex diseases , integrating whole-genome sequencing , gene dosage studies , and neurocognitive phenotyping . Key emphases include schizophrenia risk mechanisms, cardiovascular remodeling in congenital heart disease, and population-specific genetic effects. Recent work leverages cross-ancestry genomic analyses and multimodal trait integration to dissect gene-environment interactions. Analysis of 2024-2025 publications reveals accelerating focus on copy-number variant impacts across cognitive and physiological traits, with growing attention to liver-related genetic regulation and personalized brain network mapping. Collaborative studies consistently incorporate large pedigree designs and transdisciplinary methodologies spanning psychiatry, cardiology, and computational biology. No details regarding scientific awards, student mentorship, grant funding, or laboratory teams were provided in the source material.
Joakim Sundnes is a Chief Research Scientist and Research Professor at the Department of Scientific Computing, Simula Research Laboratory. He specializes in computational physiology, cardiac biomechanics, and mathematical modeling of cardiovascular systems. Key Research Areas: Cardiac electromechanics, computational fluid dynamics in cardiology, uncertainty quantification in cardiac models, and mechano-electric feedback mechanisms Recent Trends: Focus on patient-specific modeling, left atrial flow dynamics, right ventricular mechanics in pulmonary hypertension, and personalized treatment simulations Scientific Contributions: Active participant in international conferences and editorial work. Co-author of multiple benchmark studies and educational texts on physiological modeling.
Dr. Michael Lee is an Assistant Professor of Medicine in the School of Medicine at the University of California, San Francisco (UCSF), specializing in pulmonary vascular diseases with a particular focus on pulmonary hypertension related to schistosomiasis and connective tissue disorders. His research integrates metabolomics, immunology, and vascular biology to uncover disease mechanisms and identify novel therapeutic targets. Dr. Lee completed his medical training at New York University, earning his MD in 2013, followed by Internal Medicine Residency (2016) and service as Chief Resident (2017). He further specialized through a Pulmonary Sciences and Critical Care Medicine Fellowship at the University of Colorado, completed in 2020. His research program centers on the metabolic underpinnings of pulmonary hypertension, with significant contributions to understanding the roles of macrophages, T cells, and metabolic dysregulation in disease pathogenesis. Dr. Lee's work has established important connections between parasitic infections, autoimmune disorders, and pulmonary vascular pathology, with increasing emphasis on metabolomics approaches to study transpulmonary gradients and cellular metabolism. Analysis of Dr. Lee's publication record reveals a sophisticated research trajectory focused on the intersection of pulmonary hypertension with infectious diseases (particularly schistosomiasis), connective tissue disorders, and metabolic pathways. His recent work demonstrates methodological sophistication through metabolomics integration and has expanded into exercise physiology applications and novel therapeutic approaches for pulmonary hypertension. Fulbright U.S. Scholar (2022-2023) NIH K08 Career Development Award recipient (2023-2028) U.S. Department of Defense grant recipient (2022-2025) CHEST Foundation Research Grant recipient (2021-2022) Dr. Lee serves as Principal Investigator on multiple significant research projects totaling millions in funding. His NIH K08 award investigates hypoxia inducible factor-1-dependent glycolysis in lung interstitial macrophages related to schistosomiasis-induced pulmonary hypertension. He also leads a Fulbright U.S. Scholar project on transpulmonary metabolomics in systemic sclerosis-associated pulmonary arterial hypertension and a Department of Defense project examining dysregulated pulmonary vascular metabolism. His research has established important connections between parasitic infections, autoimmune disorders, and pulmonary vascular disease. Dr. Lee collaborates extensively with the Graham laboratory at UCSF and maintains international research partnerships in Ethiopia and Zambia studying schistosomiasis-associated pulmonary hypertension. His work involves multidisciplinary teams including immunologists, metabolomics specialists, and clinicians specializing in pulmonary vascular diseases. He is actively involved in the Division of Pulmonary and Critical Care Medicine at UCSF, contributing to both clinical care and research initiatives focused on rare pulmonary vascular disorders.
Peter Backx is a Full Professor in the Department of Biology at York University and Canada Research Chair in Cardiovascular Biology. He is also an Emeritus Professor at the University of Toronto and a Senior Scientist at the University Health Network. His academic journey includes a B.Sc., M.Sc., DVM (University of Guelph), and Ph.D. (University of Calgary), followed by postdoctoral training at Johns Hopkins University. His research focuses on cardiac physiology, ion channels, arrhythmias, and stem cell applications in cardiovascular biology. Dr. Backx has secured over $14M in research funding and published over 200 articles in top journals. He has supervised 26 graduate students and 17 postdoctoral fellows. His awards include Fellowships from the Royal Society of Canada and American Heart Association, as well as the Lowell Langille Mentorship Award. His work emphasizes mechanisms underlying heart disease, including atrial fibrillation and heart failure, with a focus on translational applications like tissue-specific drug delivery. Key research areas include ion transport, myocardial signaling, and cardiac development using pluripotent stem cells. He has pioneered models of atrial fibrillation and engineered cardiac tissues. Recent studies explore TNF-alpha’s role in exercise-induced atrial remodeling and therapeutic strategies for Duchenne muscular dystrophy. Dr. Backx’s labs integrate electrophysiology, proteomics, and tissue engineering to advance cardiovascular medicine.
Muammer Karakayali serves as an Assistant Professor in the Department of Internal Medicine at Kafkas University Faculty of Medicine, specializing in cardiology with a focus on electrophysiology, hypertension, and coronary artery disease. With over 100 publications and an h-index of 14 (Google Scholar), his research spans cardiac biomarkers, arrhythmia prediction, and post-COVID cardiac complications. PhD from Health Sciences University (2014-2019) Bachelor's Degree from Trakya University Faculty of Medicine (2008-2014) His research interests center on inflammatory biomarkers in cardiovascular disease, circadian blood pressure patterns, and cardiac manifestations of systemic conditions. Key areas include atrial fibrillation prediction using electrocardiographic parameters (P-wave peak time, QRS-T angle), MINOCA/INOCA pathophysiology, and risk stratification in acute coronary syndromes. His work employs advanced methodologies including speckle-tracking echocardiography and analysis of hematological indices. Karakayali leads the MORCOR-TURK LGI study on leuko-glycemic index in coronary care units and participates in the TRAFFIC Study on real-world atrial fibrillation management. His publication trends show increasing focus on post-COVID cardiac sequelae since 2020, with significant contributions to understanding arrhythmia mechanisms in inflammatory states. Young Cardiologists of the Year Award - First Place (2024) Dr. Ümit Aker Most Successful TKD Archive Article Awards (2024) He maintains extensive collaborations with 188 researchers including Timor Omar (43 joint publications) and İnanç Artaç (44 joint publications). His teaching portfolio includes 71 courses spanning EKG interpretation, pacemaker applications, and arrhythmia management across medical education levels. As an active member of the European Society of Cardiology (ESC ID: 852743) and European Heart Rhythm Association (Silver Member), he contributes to advancing clinical cardiology practice in Turkey.
Gareth Morgan, MD is a Professor in the Department of Pediatrics-Cardiology at the University of Colorado Anschutz Medical Campus School of Medicine. He serves as a Congenital Interventional Cardiologist with clinical appointments at UCHealth Adult Congenital Heart Disease and Children's Hospital Colorado. His professional affiliations include membership in the Royal College of Pediatrics and Child Health, General Medical Council, Medical Protection Society, British Congenital Cardiac Association, Association of European Pediatric Cardiology, Society for Cardiac Angiography and Interventions, Pediatric Interventional Cardiology Early Career Society, and the American Heart Association. Dr. Morgan's research focuses on pediatric and congenital interventional cardiology, particularly innovative percutaneous treatments for congenital heart defects. His work emphasizes reducing radiation exposure and contrast use during procedures while improving outcomes for complex congenital heart disease patients. He has published extensively on pulmonary valve interventions, stent technologies, and advanced imaging techniques for congenital heart disease. His clinical interests center on the treatment of congenital heart disease through minimally invasive procedures (cardiac catheterization), with a specialty in complex interventions for pulmonary valve disease, pulmonary vein stenosis, and Fontan circulation management. Dr. Morgan follows an integrated approach to congenital heart disease that combines fetal, pediatric, and adult congenital heart disease care. Dr. Morgan has received the Madeleine Steel Fellowship from the British Cardiac Society (2008) and has been active in developing new techniques and technologies in congenital interventional cardiology. His recent work has focused on virtual reality applications for patient screening, fusion imaging to reduce radiation exposure, and novel stent and valve technologies for complex congenital heart disease. He has been instrumental in several multicenter trials including the Alterra Adaptive Prestent study for pulmonary regurgitation and the ASSURED Trial for atrial septal defect closure. His educational background includes MB ChB and BAO from The Queen's University of Belfast, UK (1999), MPhil from Queen's University of Belfast (2006), residency in Pediatric Cardiology (2004), and fellowships at Hospital for Sick Children, Canada and University Hospitals Bristol.
Dr. Sonya Babu-Narayan is a Reader at the National Heart and Lung Institute, Imperial College London, and a Consultant Cardiologist at the Royal Brompton and Harefield NHS Trust. She also serves as Associate Medical Director at the British Heart Foundation (2018–present). Her academic roles include leadership in adult congenital heart disease (ACHD) research, cardiovascular magnetic resonance (CMR) technology, and clinical guidelines. She holds a PhD from Imperial College London and completed advanced clinical training in cardiology across multiple prestigious institutions. Education: MB BS (Merit in Clinical Medicine), University College London (1998) BSc First Class Honours (Neurosciences), University College London (1994) MRCP (UK), Royal College of Physicians (2001) PhD, Imperial College London Research Interests: Her work focuses on adult congenital heart disease , CMR innovations , and clinical outcomes in ACHD . She co-authored the 2020 ESC ACHD guidelines and pioneered CMR-based risk stratification models. Her research integrates biomedical engineering, public health, and clinical cardiology. Awards and Recognition: BHF Intermediate Clinical Research Fellowship (2012–2018) American Heart Association Cardiovascular Disease in the Young Award (2006) 2022 Inspiring Communicator Award (for science-art collaborations) Advising/Grants: She led the BHF-funded INDICATOR cohort study and collaborated with Wellcome Trust on the Fluent Heart project, blending medicine with arts. She advises parliamentary committees on healthcare policy. Collaborations and Labs: Active in the National Heart and Lung Institute , she leads international studies like the COaCHeD project and chairs ACHD imaging guidelines committees.
Dr. Jason Hong is a board-certified pulmonary and critical care physician at University of California, Los Angeles (UCLA), providing care in Westwood and Santa Monica hospitals. As a Clinical Assistant Professor at the David Geffen School of Medicine, he focuses on pulmonary vascular diseases including pulmonary arterial hypertension (PAH) , combining experimental research with computational approaches to uncover molecular mechanisms. Undergraduate: University of California, Berkeley MPH: University of California, Berkeley Medical Degree: Loma Linda University PhD: Molecular, Cellular, and Integrative Physiology at UCLA Residency: Internal Medicine at Columbia University Fellowship: Pulmonary and Critical Care at UCLA Hong's research spans translational studies of PAH pathobiology, including single-cell transcriptomics , multi-omics analysis , and molecular imaging . His work identifies novel therapeutic targets like Asporin , TM4SF1 , and LOXL2 , while exploring sex differences and neuroinflammatory pathways in pulmonary hypertension. Recent publications highlight trends in single-cell sequencing , digital spatial profiling , and RNA-binding protein functions . His team integrates preclinical models with clinical sample analysis to bridge molecular insights to patient therapies, particularly in right ventricular failure and pulmonary fibrosis comorbidities. Hong collaborates with UCLA's multidisciplinary researchers in cardiovascular physiology and pulmonary medicine, though no specific lab or grant details are mentioned in the provided text. His work appears in journals including Circulation , Am J Respir Cell Mol Biol , and Hypertension .
Kendall Hunter, PhD serves as Associate Professor in the Department of Bioengineering at the University of Colorado School of Medicine, Anschutz Medical Campus. Affiliated with both the University of Colorado Denver and Children's Hospital Colorado, Hunter maintains clinical practice at the Aurora campus (13123 East 16th Ave). The academic appointment resides within the College of Engineering, Design and Computing's Bioengineering department, which operates jointly across the Anschutz Medical Campus and Denver campus. Hunter's research focuses at the intersection of cardiovascular physiology, neural engineering, and medical imaging technologies. Primary investigation areas include right ventricular-pulmonary arterial coupling, Fontan circulation hemodynamics, and advanced cardiac imaging techniques like 4D flow MRI. The work frequently addresses clinical challenges in pulmonary hypertension, congenital heart disease, and metabolic disorders affecting cardiovascular function. Recent publications demonstrate strong emphasis on developing computational models and novel imaging algorithms for cardiovascular assessment. Analysis of the 15 most recent publications reveals consistent focus on ventricular-vascular interactions, particularly in challenging clinical populations including pediatric patients with pulmonary hypertension, Fontan circulation, and metabolic disorders. The research methodology heavily utilizes advanced imaging modalities (4D flow MRI, echocardiography), hemodynamic monitoring, and computational analysis techniques including principal component analysis for complex clinical data. Principal investigator for neural engineering research within the Bioengineering department Active collaborator with Children's Hospital Colorado clinical teams Involved in graduate education through the Neural Engineering certificate program Hunter's laboratory work connects closely with the Center for Bioengineering at Bioscience 2 (12705 East Montview Boulevard), leveraging the unique co-location of engineering and medical facilities at the Anschutz campus. Current research directions include developing ultrasound algorithms for critical care applications and investigating perivascular adipose tissue interactions in metabolic disease models.
George (Rick) Stouffer, MD, is the Ernest and Hazel Craige Distinguished Professor of Medicine in the Division of Cardiology and Professor of Biomedical Engineering at the University of North Carolina at Chapel Hill. His dual appointment bridges clinical cardiology and engineering, underlining a career focused on translating hemodynamic insights into improved patient care. Education & Training: While explicit educational credentials are not listed in the provided text, Dr. Stouffer’s academic rank and extensive scholarly output imply completion of medical school, internal-medicine residency, and cardiology fellowship, most likely at UNC-Chapel Hill or affiliated institutions. Research Focus: Dr. Stouffer’s work centers on interventional cardiology, coronary hemodynamics, and precision antiplatelet therapy guided by pharmacogenomics (especially CYP2C19 genotype). Additional themes include rural-urban cardiovascular disparities, mechanical circulatory support, and the hemodynamics of complex pericardial and valvular disorders. His recent publications integrate machine-learning models to predict ischemic outcomes and optimize PCI strategies. Recent Publication Landscape (2024–2025): Across 30+ papers released in 2024–2025, dominant trends include: rigorous assessment of hemodynamics in cardiogenic shock, intracoronary thrombolysis, percutaneous coronary interventions for chronic total occlusions, and real-world implementation of genotype-guided P2Y12 inhibitor therapy. A recurring motif is the evaluation of disparities—rural versus urban, Black versus non-Black patients—in both access and outcomes after PCI. Scientific Awards & Honors: The text explicitly mentions the Ernest and Hazel Craige Distinguished Professorship in Medicine as a named chair; no additional medals, fellowships, or society honors are detailed in the source provided. Advising & Grants: While the supplied material does not enumerate graduate students, post-docs, or funded-grant details, Dr. Stouffer’s prolific multi-institutional collaborations and registry-based studies (e.g., Precision PCI Registry) imply robust ongoing funding and a substantial mentoring role. Laboratory & Team: No specific laboratory name or team roster appears in the text; however, his cross-disciplinary appointment in both Cardiology and Biomedical Engineering suggests active collaboration with bioengineers, clinical interventionalists, and outcomes-research faculty at UNC.
Dr. Vivian Mo is a Clinical Professor of Medicine and Interim Chief of the Division of Cardiology at the Keck School of Medicine of USC. She also serves as Chief Medical Officer of USC Care Medical Group and Director of the Women's Cardiovascular Center at USC. Her roles include medical education leadership in the cardiovascular fellowship program and advancing clinical programs in structural heart disease, echocardiography, and interventional procedures such as TAVR and MitraClip. Dr. Mo completed her internal medicine residency and cardiology fellowship at the University of Texas Southwestern Medical Center. Her research focuses on right ventricular function in pulmonary hypertension, echocardiographic measures in cardiac tamponade, and cardiovascular outcomes in women. She is a co-investigator on studies involving MRI evaluation of carotid plaque composition and the VIRGO trial examining gender disparities in myocardial infarction outcomes. She has held leadership roles in expanding the division's clinical reach to satellite facilities and building a faculty specializing in interventional cardiology, electrophysiology, heart failure, and advanced imaging. Dr. Mo is a Fellow of the American College of Cardiology and American Society of Echocardiography. Her awards include the Charles S. Houston Award (2007) and recognition for excellence in psychology (1996). She speaks English, Mandarin, and Spanish.
Sheldon Magder is a Professor in the Department of Physiology at McGill University. He is affiliated with the Critical Care Division at the MUHC-Glen in Montreal, Quebec. His research focuses on cardiovascular physiology, particularly the control and distribution of peripheral blood flow during exercise, heat stress, and shock. Dr. Magder holds an M.D. from the University of Toronto. His work integrates clinical practice with physiological mechanisms, emphasizing hemodynamic monitoring, fluid management, and cardiopulmonary interactions in critical care settings. He has contributed extensively to understanding central venous pressure, right ventricular function, and the physiological basis of shock. His research also addresses challenges in mechanical ventilation, acid-base balance, and the application of Guytonian cardiovascular models in clinical decision-making. Education: M.D., University of Toronto. Research interests include fluid resuscitation strategies, hemodynamic monitoring technologies, and the pathophysiology of acute right heart failure. His recent studies explore the interplay between respiratory and cardiovascular systems in critical illness, with a focus on translational physiology. Dr. Magder’s publications highlight advancements in clinical guidelines for IV fluids, the role of neuropeptides in endothelial function, and the optimization of vasoactive therapies in shock. His scientific contributions span over four decades, with a focus on bridging basic physiology and clinical practice. Notable areas include the reinterpretation of central venous pressure, the mechanistic understanding of intraabdominal hypertension, and the physiological basis of cardiopulmonary monitoring in the ICU. His work has informed international guidelines for fluid management and mechanical ventilation protocols.
